PET/MRI in oncological imaging: State of the art

Usman Bashir, Andrew Mallia, James Stirling, John Joemon, Jane MacKewn, Geoff Charles-Edwards, Vicky Goh, Gary J. Cook*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

37 Citations (Scopus)


Positron emission tomography (PET) combined with magnetic resonance imaging (MRI) is a hybrid technology which has recently gained interest as a potential cancer imaging tool. Compared with CT, MRI is advantageous due to its lack of ionizing radiation, superior soft-tissue contrast resolution, and wider range of acquisition sequences. Several studies have shown PET/MRI to be equivalent to PET/CT in most oncological applications, possibly superior in certain body parts, e.g., head and neck, pelvis, and in certain situations, e.g., cancer recurrence. This review will update the readers on recent advances in PET/MRI technology and review key literature, while highlighting the strengths and weaknesses of PET/MRI in cancer imaging.

Original languageEnglish
Pages (from-to)333-357
Number of pages25
Issue number3
Publication statusPublished - 1 Jan 2015


  • Cancer
  • Diagnosis
  • Imaging
  • MR-PET


Dive into the research topics of 'PET/MRI in oncological imaging: State of the art'. Together they form a unique fingerprint.

Cite this